Navigation Links
Humacyte Presents Interim First-in-Human Data For Investigational Bioengineered Blood Vessel at the American Heart Association (AHA) Scientific Sessions 2013
Date:11/20/2013

six months.

The interim patient data suggest that the Humacyte investigational bioengineered vessel may potentially be associated with low rates of vessel clotting, low infection rates, and low rates of surgical interventions. Low rates of clotting and intervention are consistent with preclinical data from animal testing that indicated little intimal hyperplasia. Preclinical data also indicated that, in animals, investigational vessels were remodeled to become living and more similar to native tissue. To date in the Polish study, the investigational vessel has remained open to blood flow (patent), with no indication of an immune response in recipients, no aneurysms (abnormal widening or ballooning of part of an artery due to weakness in the blood vessel wall), and flow rates and durability suitable for dialysis. Longer follow-up and additional clinical studies will be required to confirm these preliminary observations.

Co-authors on the presentation were: Drs. Marek Ilzecki, Tomasz Jakimowicz, Alison Pilgrim, Stanislaw Przywara, Jacek Szmidt, Jakub Turek, Wojciech Witkiewicz, Norbert Zapotoczny, Tomasz Zubilewicz, and Laura Niklason.

Described by Investigator as "Breakthrough Investigational Technology"

"Based on our experience to date, this is breakthrough investigational technology," said Principal Investigator Prof. Tomasz Zubilewicz, M.D., Ph.D., head, Department of Vascular Surgery and Angiology, Medical University of Lublin, Poland. "The investigational bioengineered vessel seems like it could have the potential to be shown to be superior to synthetic grafts in vascular access for hemodialysis in all aspects. This technol
'/>"/>

SOURCE Humacyte, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
3. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
4. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
5. Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®
6. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
7. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
8. Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting
9. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
10. Berg Pharma presents at ASCO, poised to lead field in cancer metabolism with Phase II trials of BPM 31510
11. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Electrophysiologist Kevin Makati, M.D. with St. ... Boston, MA to speak about ... Society conference. These scientific sessions drew more than ... people and technology that propel their specialty forward. ... invasive cardiac operation that combines the expertise of ...
(Date:5/22/2015)... 2015 The North American dental lasers ... estimated to reach $90.7 million by 2019, at a CAGR ... the TOC of North America Dental Lasers Market for an ... various tables and figures. http://www.micromarketmonitor.com/market/north-america-dental-lasers-1771208223.html ... report.   Dental lasers are specifically used ...
(Date:5/22/2015)...  The U.S. Food and Drug Administration,s (FDA) ... biosimilar product approved in the United ... the contract manufacturing organization (CMO) industry, according to ... to the production of small-molecular drugs and lacks ... healthcare market research publisher,s report, Biopharmaceutical and ...
Breaking Medicine Technology:St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... Columbia Laboratories, Inc. (Nasdaq: CBRX ), ... today confirmed that the Advisory Committee for Reproductive Health ... is scheduled to review Columbia,s New Drug Application (NDA) ... of preterm birth in women with short uterine cervical ...
... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... been named to the role of Executive Vice President ... employment with Valeant, which is expected to be December ... Sachs where he was the chief operating officer for ...
Cached Medicine Technology:Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 2Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 3Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 4Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer 2Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer 3
(Date:5/26/2015)... Ontario, CA (PRWEB) May 26, 2015 ... hand protection since 1997, is excited to announce the ... the first medical grade gloves made of polyethylene (PE) ... diagnosis, examination and general applications. , The ... used in making sandwiches or mixing salads but our ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 On June ... a complimentary live online broadcast at 6:00pm PST/9:00 pm ... and Trivedi Master™ Alice Branton welcomes the public to ... a night of profound knowledge, transformation and enlightenment. ... Effect® and no previous knowledge, experience or other prerequisites ...
(Date:5/26/2015)... EMIGSVILLE, PA (PRWEB) May 26, 2015 ... oXygen® XML Editor with the Vasont® CCMS to ... process. Vasont Systems, a top component content management ... Universal Integrator (VUI) extension supports oXygen XML Editor ... , The Vasont Universal Integrator extension merges key ...
(Date:5/26/2015)... 26, 2015 General Networks Corporation ... Corporation. The alliance ensures joint customers will benefit ... General Networks’ expertise in building enterprise content and ... will help customers integrate, manage and operationalize their ... processes. , “Our customers are seeking tools to ...
(Date:5/26/2015)... Foot and Ankle Specialists of ... Leone (Pasadena and Baltimore Divisions) was recently presented ... Medical Association (MPMA) President from 2013 to 2015 at ... Doctorate in Podiatric Medicine from Temple University in 1999 ... in Voorhees, New Jersey. Dr. Leone is an ...
Breaking Medicine News(10 mins):Health News:Enov8® Exam Glove by Adenna® Approved by U.S. FDA 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 3Health News:Vasont Systems Certifies the Integration between the Vasont® Component Content Management System and oXygen® XML Editor 17.0 2Health News:General Networks Corporation Announces Alliance with MarkLogic 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives MPMA Service Award 2
... , FRIDAY, Sept. 9 (HealthDay News) -- College ... power over time, but smaller improvements in speed and ... physical capabilities of 289 Division III college players throughout ... senior year, the players, body mass increased an average ...
... News) -- More than one-half of all adverse drug ... according to a new study. In addition, prior ... which include drug overdoses and internal bleeding associated with ... are life-threatening, said the Swedish researchers. This widespread problem, ...
... , FRIDAY, Sept. 9 (HealthDay News) -- Fundraising methods such ... the ability to make a donation on state income tax ... and prevention programs in the United States, a new study ... enable taxpayers to check a box on their income tax ...
... Coukell, a pharmacist and director of medical programs at ... Health Education Labor and Pensions Committee about the need ... U.S. drug supply. Nearly 80 percent ... Increasingly, Americans rely on pharmaceuticals that are produced ...
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, Sept. ... anxious about caring for their infant. But sometimes that concern ... go wrong. Experts call that condition postpartum obsessive compulsive ... prevent their fears from coming true, such as endlessly washing ...
... (HealthDay News) -- People are at much higher risk ... according to a new study. Canadian researchers found ... is likely to develop COPD, which they called "one of ... emphysema and chronic bronchitis, and the overall risk for developing ...
Cached Medicine News:Health News:Over Half of Adverse Drug Reactions in Hospitals Are Preventable: Study 2Health News:When Protecting Baby Becomes an Obsession 2Health News:When Protecting Baby Becomes an Obsession 3Health News:Risk for COPD Higher Than Thought: Study 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: